|Over a week ago|
Dow Inc. initiated with a Peer Perform at Wolfe Research » 16:3006/0906/09/21
Wolfe Research analyst…
Wolfe Research analyst Josh Silverstein initiated coverage of Dow Inc. with a Peer Perform rating. He started coverage on 14 chemical companies stating that he believes chemicals as a group are well positioned coming out of the COVID-19 downturn. He is initiating with an Overweight rating on the electronic chemicals subsector, but starting with Market Weight ratings on the industrial gases and diversified and basic chemicals subsectors.
Dow Inc. price target raised to $78 from $69 at Argus » 08:1406/0806/08/21
Argus analyst Bill…
Argus analyst Bill Selesky raised the firm's price target on Dow Inc. to $78 from $69 and keeps a Buy rating on the shares. In the near term, the company should benefit from stronger pricing for commodity chemicals and increased demand in North America and China, the analyst tells investors in a research note. Selesky adds that Dow Inc. is also seeing strong demand for packaging and consumer durable products related to the distribution of coronavirus vaccines.
Dow Inc. price target raised to $75 from $66 at Deutsche Bank » 06:5306/0406/04/21
Deutsche Bank analyst…
Deutsche Bank analyst David Begleiter raised the firm's price target on Dow Inc. to $75 from $66 and keeps a Hold rating on the shares after the company announced that it expects Q2 EBITDA to be $400M-$500M, or 14%-17%, higher than the consensus of $2.9B.
Dow Inc. price target raised to $75 from $66 at JPMorgan » 07:3106/0306/03/21
JPMorgan analyst Jeffrey…
JPMorgan analyst Jeffrey Zekauskas raised the firm's price target on Dow Inc. to $75 from $66 and keeps an Overweight rating on the shares. Near-term business fundamentals for Dow and Lyondell "continue to improve sharply" as polyethylene prices began the year near 50c per pound and are now close to 80c, Zekauskas tells investors in a research note.
|Over a month ago|
Dow Inc. downgraded to Neutral from Buy at Goldman Sachs » 05:4105/1105/11/21
Goldman Sachs analyst…
Goldman Sachs analyst Robert Koort downgraded Dow Inc. to Neutral from Buy with a price target of $64, down from $69. The analyst is concerned that petrochemical margins may be reaching a peak after a period of "dramatic improvement" and prompt investors to "shift downstream towards more durable hybrid and specialty chemical companies."
Univar partners with Dow Inc. to distribute silicone based defoamers in Mexico » 08:0505/0305/03/21
Univar Solutions (UNVR)…
Univar Solutions (UNVR) announced an agreement with Dow (DOW) to distribute its line of silicone based defoamers DOWSIL and XIAMETER for agrochemical applications in Mexico. The expanded agreement further solidifies Univar Solutions' ability to provide a broad range of industry-leading products, solutions and expertise for its agrochemical industry customers.
Fly Intel: Top five analyst upgrades » 09:5304/2704/27/21
SCHW, UPS, DOW, SAL, CGEM
Catch up on today's…
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Charles Schwab (SCHW) upgraded to Outperform from Neutral at Credit Suisse with analyst Craig Siegenthaler estimating Schwab will generate more than $4.00 in earnings per share by 2023 and roughly $5.00 by 2024 on the view that the Federal Reserve will need to raise rates in 2023 through 2025. 2. UPS (UPS) upgraded to Hold from Sell at Berenberg with analyst William Howard saying with volume momentum gaining strength and pricing holding firm, the outlook for the global parcel names "remains benign" in 2021. 3. Dow Inc. (DOW) upgraded to Buy from Hold at Argus with analyst William Selesky saying the company is set to benefit from stronger pricing for commodity chemicals and increased demand in North America and China. 4. Salisbury Bancorp (SAL) upgraded to Buy from Neutral at DA Davidson with analyst Christopher Keith saying the stock's likely removal from the Russell 2000 index likely drove its year-to-date underperformance and created an "attractive" entry point. 5. Cullinan (CGEM) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Jeffrey Hung saying he views the risk/reward as favorable following the pullback in share price from the stock's early March peak and ahead of the CLN-081 Phase 1/2a data expected mid-year that remains "the main clinical update for Cullinan in 2021." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
Argus expects Dow Inc to benefit from stronger pricing, upgraded to Buy » 07:4904/2704/27/21
As previously reported,…
As previously reported, Argus analyst William Selesky upgraded Dow Inc. to Buy from Hold with a $69 price target. The company is set to benefit from stronger pricing for commodity chemicals and increased demand in North America and China, the analyst tells investors in a research note, adding that he is also positive on Dow's low cost structure, solid cash flow, declining capital spending requirements, and sustainable dividend. Selesky is also boosting his FY21 EPS view on Dow to $5.80 from $3.16.
Dow Inc. upgraded to Buy from Hold at Argus » 07:2004/2704/27/21
Argus analyst William…
Argus analyst William Selesky upgraded Dow Inc. to Buy from Hold with a $69 price target.
Fly Intel: Wall Street's top stories for Thursday » 16:4204/2204/22/21
T, DOW, CMG, HIG, CB, TSLA, GM, GOOGL, GOOG, BA, RNLX, TDC, DNMR, FSR
Stocks were in a narrow…